This page is in verification process.
Buyers can use information for reference only. Freshdi is not responsible for information on this page.
If you own Hubei Fuxin Medical Equipment Co., Ltd., claim it to manage this profile and connect with international buyers.

China – country flag, supplier location, company info headerChina

1.1

Verification level 0

INDUSTRIZAL ZONE, SHAYANG COUNTY

Add Favorite

|

Report Supplier

|

Business Description

Hubei Fuxin Medical Equipment Co., Ltd. was established in 1989 year (It was called Wuhan medical plastic instrument company before) and moved from Wuhan city to Shayang industrial zone in 2008.

Our total area is 66666 square meters, and our building area is 16000 square meters, and our workshop is 8200 square meters. Our main products are infusion set, blood transfusion set, precision fluid adjust infusion set, extension line, scalp vein set, disposable syringe, auto-disable syringe, insulin syringe, needle , urine bag and so on. With the advanced production line and test equipment, we have large production capacity, and our infusion (blood transfusion) set is 60,000, 000 sets and syringe is 100,000,000 pieces per year.

In strict accordance with the ISO 13485 and ISO 9001 international quality standard system, we established a management system and got the ISO 13485 Certificate signed by T U V and EC CE certificate. Our products are well sold in European, Asia, South America, Africa, for example, Italy, Greece, Russia, and Brazil and so on.

Our mission is to set famous brand base on people first, quality, innovation. Connecting the enterprise development and community responsibility, we have been bent on making progress and working for human health.

We are willing to cooperate with friends for a better future!

Business Overview

Avg Response Time

≤ 1h

Hubei Fuxin Medical Equipment Co., Ltd. has been operating since 2004, which is longer than most new medical equipment suppliers and suggests experience in the field. The company offers a wide range of products including syringes, gloves, needles, and even robots and spare parts — a mix that covers both basic medical supplies and more advanced automation. Being based in China gives access to large-scale manufacturing and low production costs, which is common for medical equipment suppliers in the region. However, none of the key verification fields — work email, phone, or business documents — are confirmed, which raises concerns about legitimacy and ability to fulfill orders reliably. Buyers should request additional proof before placing large orders or committing to long-term supply. While the product range is broad, the lack of verification makes it harder to trust the company's ability to deliver consistently. For new buyers, this means extra due diligence is needed to confirm the company's real operations and compliance with medical standards.

Export Capabilities

Declared by supplier

Hubei Fuxin Medical Equipment Co., Ltd. has been exporting since 2004.

Export start year

2004

Trade Capabilities

Business Terms

Preferred Payment Term:

Not specified

Preferred Trade Term:

Not specified

Port Of Loading:

Not specified

Accepted Currency:

USD

Trade Ability

Annual Revenue Amount:

Not specified

Numbers Of Employees:

Not specified

Avg Response Time:

-

Own this company?

Hubei Fuxin Medical Equipment Co., Ltd.

China – country flag, supplier location, claim store cardChina

Unverified

Claim store, then activate and verify to showcase products.

Supplier sign-up – promo banner, free supplier page sidebar

Medical Syringes market insight

Across Medical & HealthCare, the wider group Medical Syringes belongs to, Freshdi lists 9 active supply listings from 9 suppliers in 6 countries, as of 18 November 2026. Suppliers across Medical & HealthCare, the wider group Medical Syringes belongs to, come from 6 countries, led by India at 22.2%, on Freshdi as of 18 November 2026. Buyer inquiry volume across Medical & HealthCare, the wider group Medical Syringes belongs to, rose 100% on Freshdi in the 30 days to 18 November 2026 against the 30 days before, with 103.41% volatility in monthly inquiry and quotation activity over 338 days.